<DOC>
	<DOC>NCT00203125</DOC>
	<brief_summary>This study is to determine if Tyramine has any side effects on patients receiving 0.5mg, 1mg of Rasagiline or Placebo</brief_summary>
	<brief_title>A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<mesh_term>Tyramine</mesh_term>
	<criteria>Men and women with idiopathic Parkinson's disease (PD) who have met inclusion criteria for PRESTO, and have completed the 26week PRESTO study. The subject should be available to participate in the substudy immediately following the last PRESTO visit (same day). Subjects must continue PRESTO study drug until the morning of the Tyramine SubStudy. Subjects must provide separate informed consent to participate in the Tyramine SubStudy. Subjects must not have a history of intracranial aneurysm or stroke. Subjects should not have uncontrolled hypertension, defined as systolic pressure &gt; 160 mmHg, or diastolic pressure &gt; 90 mmHg.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>